Erin Fromm
Family · Irvine, CANPI 1073255238
Payments from drug & device makers
Across 245 payments — averaging $68.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$3K
- TG Therapeutics, Inc.$3K
- Argenx US, Inc.$2K
- UCB, Inc.$2K
- AstraZeneca$1K
- AbbVie$740
- plus $4K from 25 others
What the payments were for
- Consulting fees$6,36838%
- Speaking & faculty fees$1,92012%
- Travel & lodging$1,84311%
- Food & beverage$6,53339%
- Education$10%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 21 | $3,364 |
| TG Therapeutics, Inc. | 13 | $2,771 |
| Argenx US, Inc. | 15 | $2,193 |
| UCB, Inc. | 30 | $2,002 |
| AstraZeneca | 18 | $1,419 |
| AbbVie | 38 | $740 |
| Genentech, Inc. | 4 | $726 |
| Janssen Scientific Affairs, LLC | 1 | $653 |
| Novartis | 20 | $542 |
| ANI Pharmaceuticals, Inc. | 15 | $334 |
| Biogen | 10 | $332 |
| EMD Serono, Inc. | 7 | $274 |
| Lilly USA, LLC | 8 | $199 |
| Bristol Myers Squibb | 8 | $166 |
| Sanofi | 3 | $156 |
| Pfizer | 6 | $122 |
| Banner Life Sciences, LLC | 4 | $98 |
| Neurocrine Biosciences, Inc. | 3 | $94 |
| SK Life Science, Inc. | 3 | $76 |
| Eisai Inc. | 3 | $72 |
| Genentech USA, Inc. | 3 | $53 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $50 |
| Acadia Pharmaceuticals Inc | 2 | $40 |
| Alnylam Pharmaceuticals Inc. | 1 | $33 |
| Lundbeck LLC | 1 | $32 |
| Teva Pharmaceuticals USA, Inc. | 1 | $28 |
| Merz Pharmaceuticals, LLC | 1 | $27 |
| Hologic Sales And Service, LLC | 1 | $22 |
| Cycle Pharmaceuticals Inc | 1 | $20 |
| Mallinckrodt Hospital Products Inc. | 1 | $14 |
| Johnson & Johnson | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$16,664 in reported general payments places this provider in the 95th percentile of 10,634 family providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Kesimpta PenOfatumumab | 13 | $127,889 |
| GammaplexImmun Glob G(Igg)/Gly/Iga 0-50 | 19 | $76,051 |
| Memantine Hcl | 110 | $3,813 |
| Donepezil Hcl | 184 | $1,947 |
| Levetiracetam | 28 | $1,233 |
| Pyridostigmine Bromide | 14 | $858 |
| Gabapentin | 33 | $656 |
| Levetiracetam ErLevetiracetam | 14 | $564 |
| Atorvastatin Calcium | 42 | $431 |
| Escitalopram Oxalate | 15 | $271 |
| ClopidogrelClopidogrel Bisulfate | 12 | $181 |
| Sertraline Hcl | 23 | $180 |
| Venlafaxine Hcl | 11 | $109 |
| Trazodone Hcl | 12 | $56 |
Paid to pharmacies, not to this prescriber.
Other family in Irvine
- Lori RobertsonChino Hills$475K
- Annette ShonLos Angeles$406K
- Nancy GardettoSan Diego$394K
- Lisa HigginsHanford$311K
- Jennifer TougasBakersfield$302K
- Kim SchaferSacramento$288K
- Dawn MeyerSan Diego$270K
- Jennifer KangCerritos$255K
- Jenine StoneEscondido$231K
- Erin DwyerSan Diego$189K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.